Trial intelligence / Profile preview

17-OHPC for Prevention of Preterm Delivery

NCT00331695Phase 4Completed

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Jun 2006
Primary completion
May 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of hydroxyprogesterone caproate in preterm birth, sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2006; status: completed.

02

Drugs

hydroxyprogesterone caproate
03

Conditions

preterm birth

Beyond the preview

Go deeper on NCT00331695.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00331695.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call